Comprehensive Analysis of Berberis aristata DC. Bark Extracts: In Vitro and In Silico Evaluation of Bioaccessibility and Safety
Nutrients · 2024
DOI: 10.3390/nu16172953 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nutrients, 2024. Verfasst von Giovanna Rigillo und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, 41125 Modena, Italy. Hauptthemen laut MEDLINE: Berberis, Plant Extracts, Plant Bark, Berberine. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 96 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Berberine (BER) is an alkaloid found, together with other protoberberinoids (PROTBERs), in several species used in medicines and food supplements. While some herbal preparations containing BER and PROTBERs, such as Berberis aristata DC. bark extracts, have shown promising potential for human health, their safety has not been fully assessed. Recently, the EFSA issued a call for data to deepen the pharmacokinetic and pharmacodynamic understanding of products containing BER and PROTBERs and to comprehensively assess their safety, especially when used in food supplements. In this context, new data were collected in this work by assessing: (i) the phytochemical profile of 16 different commercial B. aristata dry extracts, which are among the most widely used preparations containing BER and PROTBERs in Europe; (ii) the In Vitro and In Silico investigation of the pharmacokinetic properties of BER and PROTBERs; (iii) the In Vitro cytotoxicity of selected extracts in different human cell lines, including tests on hepatic cells in the presence of CYP450 substrates; (iv) the effects of the extracts on cancer cell migration; and (v) the In Vitro molecular effects of extracts in non-cancer human cells. Results showed that commercial B. aristata extracts contain BER as the main constituent, with jatrorrhizine as main secondary PROTBER. BER and jatrorrhizine were found to have a good bioaccessibility rate, but they interact with P-gp. B. aristata extracts showed limited cytotoxicity and minimal interaction with CYP450 substrates. Furthermore, tested extracts demonstrated inhibition of cancer cell migration and were devoid of any pro-tumoral effects in normal cells. Overall, our work provides a valuable overview to better elucidate important concerns regarding botanicals containing BER and PROTBERs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, 41125 Modena, Italy.
- Laboratory of Italian Society of Phytoterapy-SIFITLab, 53100 Siena, Italy.
- Department of Physical Sciences, Earth and Environment, University of Siena, 53100 Siena, Italy.
- Department of Psychiatry and Behavioral Sciences, University of Miami, Miami, FL 33136, USA.
- Department of Life Sciences, University of Modena and Reggio Emilia, 41125 Modena, Italy.
- Consorzio Interuniversitario Biotecnologie (CIB), 34148 Trieste, Italy.
ORCID-Profile: Giovanna Rigillo, Giorgio Cappellucci, Federica Vaccaro, Elisabetta Miraldi, Luca Pani, Fabio Tascedda, Renato Bruni, Marco Biagi
Zitieren
APA
Rigillo, G., Cappellucci, G., Baini, G., Vaccaro, F., Miraldi, E., Pani, L., Tascedda, F., Bruni, R., & Biagi, M. (2024). Comprehensive Analysis of Berberis aristata DC. Bark Extracts: In Vitro and In Silico Evaluation of Bioaccessibility and Safety. Nutrients. https://doi.org/10.3390/nu16172953
Vancouver
Rigillo G, Cappellucci G, Baini G, Vaccaro F, Miraldi E, Pani L, et al. Comprehensive Analysis of Berberis aristata DC. Bark Extracts: In Vitro and In Silico Evaluation of Bioaccessibility and Safety. Nutrients. 2024. doi:10.3390/nu16172953
BibTeX
@article{Rigillo2024,
author = {Rigillo, Giovanna and Cappellucci, Giorgio and Baini, Giulia and Vaccaro, Federica and Miraldi, Elisabetta and Pani, Luca and Tascedda, Fabio and Bruni, Renato and Biagi, Marco},
title = {Comprehensive Analysis of Berberis aristata DC. Bark Extracts: In Vitro and In Silico Evaluation of Bioaccessibility and Safety},
journal = {Nutrients},
year = {2024},
doi = {10.3390/nu16172953}
}
EUVIMED